• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Altimmune, Inc. - Common Stock (NQ:ALT)

    3.630 -0.060 (-1.63%)
    Streaming Delayed Price Updated: 1:59 PM EDT, Aug 1, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,112,044
    Open 3.620
    Bid (Size) 3.630 (10)
    Ask (Size) 3.640 (20)
    Prev. Close 3.690
    Today's Range 3.580 - 3.715
    52wk Range 2.900 - 11.16
    Shares Outstanding 77,825,450
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
    From Pomerantz LLP
    Via GlobeNewswire

    Performance

    YTD
    -48.9%
    -48.9%
    1 Month
    -14.2%
    -14.2%
    3 Month
    -29.8%
    -29.8%
    6 Month
    -48.1%
    -48.1%
    1 Year
    -42.9%
    -42.9%

    More News

    Read More
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
    From Pomerantz LLP
    Via GlobeNewswire
    ALT Investors Have Opportunity to Join Altimmune, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
    From Pomerantz LLP
    Via GlobeNewswire
    Methode Electronics, Ultragenyx Pharmaceutical And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
    Via ACCESS Newswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
    From Pomerantz LLP
    Via GlobeNewswire
    Benzinga Bulls And Bears: Nvidia, Micron, HIMS — And Markets Soar On Mideast And Tariff Relief
    Via Benzinga
    Altimmune's Fatty Liver Candidate Faces Differentiation Doubts
    Via Benzinga
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
    Via ACCESS Newswire
    Top movers in Thursday's session
    Via Chartmill
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Crude Oil Gains Over 1%; Walgreens Posts Upbeat Earnings
    Via Benzinga
    Here are the top movers in Thursday's session.
    Via Chartmill
    Gapping stocks in Thursday's session
    Via Chartmill
    Altimmune Stock Sinks After Mid-Stage Data From Fatty Liver Candidate
    Via Benzinga
    Dow Surges 200 Points; US GDP Contracts 0.5%
    Via Benzinga
    Topics Stocks
    Altimmune Stock Plummets After Mixed Results In Liver Disease Trial: Retail Sees ‘Nothing Of Substance’ To Start A Position
    Via Stocktwits
    Thursday's pre-market session: top gainers and losers
    Via Chartmill
    Altimmune, Bit Digital, Kratos Defense & Security Solutions And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga

    Frequently Asked Questions

    Is Altimmune, Inc. - Common Stock publicly traded?
    Yes, Altimmune, Inc. - Common Stock is publicly traded.
    What exchange does Altimmune, Inc. - Common Stock trade on?
    Altimmune, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Altimmune, Inc. - Common Stock?
    The ticker symbol for Altimmune, Inc. - Common Stock is ALT on the Nasdaq Stock Market
    What is the current price of Altimmune, Inc. - Common Stock?
    The current price of Altimmune, Inc. - Common Stock is 3.630
    When was Altimmune, Inc. - Common Stock last traded?
    The last trade of Altimmune, Inc. - Common Stock was at 08/01/25 01:59 PM ET
    What is the market capitalization of Altimmune, Inc. - Common Stock?
    The market capitalization of Altimmune, Inc. - Common Stock is 282.51M
    How many shares of Altimmune, Inc. - Common Stock are outstanding?
    Altimmune, Inc. - Common Stock has 283M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.